Cargando…
Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer death worldwide. Immunotherapy with immune checkpoint inhibitors (ICI) has significantly improved outcomes in some patients, however 80-85% of patients receiving immunotherapy develop primary resistance, manifesting as a lack...
Autores principales: | Rangamuwa, Kanishka, Aloe, Christian, Christie, Michael, Asselin-Labat, Marie-Liesse, Batey, Daniel, Irving, Lou, John, Thomas, Bozinovski, Steven, Leong, Tracy L., Steinfort, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151669/ https://www.ncbi.nlm.nih.gov/pubmed/37143952 http://dx.doi.org/10.3389/fonc.2023.1129195 |
Ejemplares similares
-
Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors
por: Rangamuwa, Kanishka, et al.
Publicado: (2021) -
Heterogeneity of tumour mutational burden in metastatic NSCLC demonstrated by endobronchial ultrasound sampling
por: Leong, Tracy L., et al.
Publicado: (2023) -
Increase in tumour PD-L1 expression in non-small cell lung cancer following bronchoscopic thermal vapour ablation
por: Rangamuwa, Kanishka, et al.
Publicado: (2021) -
Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer
por: Bozinovski, Steven, et al.
Publicado: (2021) -
A glimpse of the future?—bronchoscopic ablation of peripheral early stage lung cancer
por: Steinfort, Daniel P., et al.
Publicado: (2021)